Sino-Biocan

About:

Sino-Biocan focuses on the research and development of domestic tools in the field of cell and gene therapy.

Website: http://www.sino-biocan.com/

Top Investors: Dalton Venture, Sinovation Ventures, Breakthrough Capital, Grand Flight Investment, Neovision Capital

Description:

Zhongbo Ruikang focuses on the research and development of domestic tools in the field of cell and gene therapy, mainly to assist customers in realizing the "continuous, closed, disposable, consistent, scalable, automated, modular, and medical deviceization of cell preparation industrialization.

Total Funding Amount:

200M CNY

Headquarters Location:

Beijing, Beijing, China

Founded Date:

2013-01-01

Contact Email:

info(AT)sinobiocan.com

Founders:

Number of Employees:

Last Funding Date:

2024-03-04

IPO Status:

Private

Industries:

© 2025 bioDAO.ai